The phosphatidylinositol 3-kinase (PI3K) pathway is frequently altered in CRC, e.g. through mutations of PIK3CA (phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene). This evidence concerns the gene PIK3CA and colorectal carcinoma.